Lunit, a Korea-based medical artificial intelligence (AI) company, said it has signed a supply agreement with Akumin, a ...

Hanmi Pharmaceutical's dyslipidemia treatment combination drug Rosuzet (rosuvastatin+ezetimibe) has demonstrated LDL-C ...

Korea’s Dong-A ST has launched its Stelara (ustekinumab) biosimilar Imuldosa in the United States through partners Intas ...

For 30 years, metastatic urothelial carcinoma was a therapeutic dead end. Platinum-based chemotherapy remained the first-line ...

Konkuk University Medical Center has introduced two new radiation therapy devices, the Halcyon Hypersight and TrueBeam linear ...

Korea’s first government evaluation of medical imaging tests found that 1,694 institutions submitted about 3.29 million ...

With the subcutaneous (SC) version of MSD’s (known as Merck & Co. in the U.S. and Canada) blockbuster Keytruda (pembrolizumab ...

A study has found that high-dose use of inhaled corticosteroids may increase the risk of developing idiopathic pulmonary ...

The family of a patient with stage 4 lung cancer recently launched a petition on the National Assembly's platform, pleading ...

Dx&Vx said its subsidiary Avixgen has signed a global licensing agreement worth about 500 billion won ($360.3 million) with a ...

Leqembi (lecanemab), developed for Alzheimer's disease, the most common form of dementia, is often hailed as a “dream ...

Astellas Korea highlighted the clinical impact of its antibody-drug conjugate (ADC) Padcev (ingredient: enfortumab vedotin) ...